← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Bcn Biosciences, Llc
Pasadena, CA
$10,360,501
Total funding
7
Grants
Funding over time
peak $2.3M · FY2008–25$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,360,501 · 7
By mechanism
N01$6,135,026 · 1
R44$3,026,290 · 1
R43$1,199,185 · 5
Investigators at Bcn Biosciences, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
DEVELOPMENT OF MEDICAL COUNTERMEASURES TO MITIGATE AND/OR TREAT RADIATION-INDUCED LUNG INJURY AFTER A RADIOLOGICAL/NUCLEAR INCIDENT)$2,309,176
N01 · FY2016 · AI
DEVELOPMENT OF MEDICAL COUNTERMEASURES TO MITIGATE AND/OR TREAT RADIATION-INDUCED LUNG INJURY AFTER A RADIOLOGICAL/NUCLEAR INCIDENT)$1,997,849
N01 · FY2015 · AI
DEVELOPMENT OF MEDICAL COUNTERMEASURES TO MITIGATE AND/OR TREAT RADIATION-INDUCED LUNG INJURY AFTER A RADIOLOGICAL/NUCLEAR INCIDENT)$1,828,001
N01 · FY2017 · AI
Mitigation of Radiation Induced Gastrointestinal Syndrome.$1,034,934
R44 · FY2023 · AI
Mitigation of Radiation Induced Gastrointestinal Syndrome.$1,005,819
R44 · FY2024 · AI
Mitigation of Radiation Induced Gastrointestinal Syndrome.$985,537
R44 · FY2025 · AI
BCN057 as a mitigator of Radiation Induced Gastrointestinal Syndrome$299,857
R43 · FY2019 · AI
BCN057 as a mitigator of Radiation Induced Gastrointestinal Syndrome$299,668
R43 · FY2020 · AI
A dual acting drug for enhancing radiotherapeutic benefit$209,208
R43 · FY2014 · CA
A novel targeted therapy$160,735
R43 · FY2010 · CA
Botanical-derived drug discovery for cancer therapy$130,207
R43 · FY2008 · CA
Translational research in a novel anti cancer agent$99,510
R43 · FY2008 · CA